Results 101 to 110 of about 164,903 (149)

Management Challenge of Coexistence of Macrophage Activation Syndrome, Systemic Lupus Erythematosus, and Hepatitis B: Case Report. [PDF]

Clin Case Rep
Rakotonirina LN, Andrianiaina MO, Rakotonirainy OH, Ramanandafy H, Randriamifidy NH, Rapelanoro Rabenja F.   +5 more
europepmc   +1 more source

Ruxolitinib targets JAK-STAT signaling to modulate neutrophil activation in refractory macrophage activation syndrome.

Blood
Ma Y, Chen X, Wang M, Meng J, Zhu D, Chen L, Xiao Y, Yi D, Shi H, Liu H, Cheng X, Su Y, Ye J, Chi H, Zhou Z, Liu T, Yang C, Teng J, Sun Y, Jia J, Hu Q.   +20 more
europepmc   +1 more source

Macrophage Activation Syndrome in a Patient with Systemic Lupus Erythematous Triggered by Tuberculous Meningitis. [PDF]

Eur J Case Rep Intern Med
Alowais N, Zamani N, Elbadawi F, Ahmed H, Dutta P, Sharif A.   +5 more
europepmc   +1 more source

Macrophage activation syndrome-associated adult onset Still disease treatment: a scoping review of case reports and case series. [PDF]

Proc (Bayl Univ Med Cent)
Chaisrimaneepan N, Yingchoncharoen P, Pangkanon W, Kanitthamniyom C.   +3 more
europepmc   +1 more source

A Cytokine Storm Unveiled: Diagnostic Challenges of Macrophage Activation Syndrome in the Context of Undiagnosed Systemic Lupus Erythematosus in an Adolescent.

Ann Afr Med
Devadkar AP, Kanitkar SA.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

MACROPHAGE ACTIVATION SYNDROME

Journal of Clinical Gastroenterology, 2011
We recently treated a patient with adult-onset Still's disease who developed macrophage activation syndrome (MAS) secondary to disseminated histoplasmosis while being treated with adalimumab. The gastroenterology service was consulted early, before diagnosis, as the patient presented with elevated liver enzymes and disseminated intravascular ...
Bijal A, Jayakar, Philip J, Hashkes
openaire   +3 more sources

Macrophage Activation Syndrome

Arthritis & Rheumatology
Macrophage activation syndrome (MAS) is a state of immune hyperactivation that can result in life‐threatening multisystem end‐organ dysfunction. Often termed a “cytokine storm,” MAS occurs among the rheumatic diseases most typically in Still's disease but also in systemic lupus erythematosus and Kawasaki disease.
Alexei A. Grom, Grant S. Schulert
  +6 more sources

The genetics of macrophage activation syndrome

Genes & Immunity, 2020
Macrophage activation syndrome (MAS), or secondary hemophagocytic lymphohistiocytosis (HLH), is a cytokine storm syndrome associated with multi-organ system dysfunction and high mortality rates. Laboratory and clinical features resemble primary HLH, which arises in infancy (1 in 50,000 live births) from homozygous mutations in various genes critical to
Grant S, Schulert, Randy Q, Cron
openaire   +2 more sources